Chargement en cours...
Designing clinical trials to test disease-modifying agents—application to the treatment trials of Alzheimer's disease
BACKGROUND: Therapeutic trials of disease-modifying agents on Alzheimer’s disease (AD) require novel designs and analyses involving switch of treatments for at least a portion of subjects enrolled. Randomized start and randomized withdrawal designs are two examples of such designs. Crucial design pa...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3146242/ https://ncbi.nlm.nih.gov/pubmed/21335587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774510392391 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|